PEG-Intron and Rebetol ribavirin regulatory update

ENZN partner Schering-Plough Corp. (SGP, Kenilworth, N.J.) received U.S. Patent No. 6,172,046 covering the treatment of hepatitis C virus infection using the combination of PEG-Intron pegylated inter...